Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

Cardiologist, COO, Culture Changer

Start with cardiology, a specialty that has been at the forefront of positive change. Then add experience, an entrepreneurial spirit and vision.

Thumbnail

From the heart: Gunshot victim, 5, becomes donor

The family of a 5-year-old girl fatally shot inside her grandfather’s home in Milwaukee while sitting on his lap donated her heart for transplantation, according to U.S. News & World Report. The gunmen who opened fire on the house remain at large.

Thumbnail

Cardio3 snaps up valve access business

The Belgian biotechnology company Cardio3 BioSciences acquired a device maker that specializes in heart access technologies for an undisclosed amount.

Mitroflow analysis finds early, frequent valve deterioration

French cardiac surgeons raised a red flag about the 12A/LX models of the Mitroflow valve, warning of a potential epidemic of structural valve deterioration and valve-related deaths in patients implanted with the devices.

Thumbnail

Genetically high LDL-C may increase risk for aortic valve disease

According to a multinational study, genetically high levels of low-density lipoprotein cholesterol (LDL-C) may put patients at increased risk for aortic valve disease. No similar association was found between high-density lipoprotein cholesterol (HDL-C) or triglycerides and the development of aortic valve calcium and stenosis.

Cardiothoracic and Vascular Surgeons, in collaboration with Heart Hospital of Austin, first in Texas to implant Solo Smart Aortic Pericardial Heart Valve

On Oct. 16, 2014, surgeons with Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., cardiothoracic surgeons at Cardiothoracic and Vascular Surgeons, performed the procedure at Heart Hospital of Austin.

Director of the Gladstone Institute of Cardiovascular Disease elected to the Institute of Medicine

Deepak Srivastava, MD, the Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Center for Stem Cell Biology and Medicine, has been elected to the National Academy of Sciences’ Institute of Medicine (IOM).

Thumbnail

First mitral procedures show transapical implantation is feasible

Transcatheter mitral valve implantation looks like the next frontier in treatments for patients who are at high risk for surgical valve repair or replacement. In a first-in-man report, physicians demonstrated that a transapical approach is technically feasible and potentially safe.

Displaying 1209 - 1216 of 2350

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.